Effect of aqueous extract of Aegle marmelos fruit and leaf on glycemic, insulinemic and lipidemic status of type 2 diabetic model rats

Journal of Complementary and Integrative Medicine

Volumn 14, Issue 2, 2017, Pages

  Mudi, Sonchita R ^a   Akhter, Masfida ^a   Biswas, Subrata K ^b   Muttalib, Mohammad A ^c   Choudhury, Subhagata ^c   Rokeya, Begum ^a   Ali, Liaquat ^a  

^a BANGLADESH UNIVERSITY OF HEALTH SCIENCES   (Bangladesh)

^b BANGABANDHU SHEIKH MUJIB MEDICAL UNIVERSITY   (Bangladesh)

^c Bangladesh Institute of Research and Rehabilitation in Diabetes Endocrine and Metabolic Disorders   (Bangladesh)

Author keywords

Aegle marmelos; aqueous extract; fruit and leaf; HOMA; insulin resistance; type 2 diabetes mellitus

Indexed keywords

AEGLE MARMELOS EXTRACT; CHOLESTEROL; HIGH DENSITY LIPOPROTEIN CHOLESTEROL; INSULIN; ANTIDIABETIC AGENT; LIPID; PLANT EXTRACT;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANTIDIABETIC ACTIVITY; ARTICLE; BLOOD SAMPLING; CELL FUNCTION; CHOLESTEROL BLOOD LEVEL; CLINICAL EFFECTIVENESS; CONTROLLED STUDY; FEMALE; FRUIT; GLUCOSE BLOOD LEVEL; HOMEOSTASIS MODEL ASSESSMENT; HYPERLIPIDEMIA; INSULIN BLOOD LEVEL; INSULIN RESISTANCE; INSULINEMIA; INTERVENTION STUDY; MALE; NON INSULIN DEPENDENT DIABETES MELLITUS; NONHUMAN; PANCREAS ISLET BETA CELL; PLANT LEAF; RAT; TRIACYLGLYCEROL BLOOD LEVEL; AEGLE; ANIMAL; BLOOD; DRUG EFFECTS; EXPERIMENTAL DIABETES MELLITUS; LONG EVANS RAT; METABOLISM; PHYTOTHERAPY;

AEGLE; ANIMALS; BLOOD GLUCOSE; DIABETES MELLITUS, EXPERIMENTAL; DIABETES MELLITUS, TYPE 2; FEMALE; FRUIT; HYPOGLYCEMIC AGENTS; INSULIN; INSULIN RESISTANCE; INSULIN-SECRETING CELLS; LIPIDS; MALE; PHYTOTHERAPY; PLANT EXTRACTS; PLANT LEAVES; RATS, LONG-EVANS;

EID: 85020485068     PISSN: None     EISSN: 15533840     Source Type: Journal    
DOI: 10.1515/jcim-2016-0111     Document Type: Article

References (32)

1. Lozano R, Naghavi M, Foreman K, Lim S, Shibuya K, Aboyans V, et al. Global and regional mortality from 235 causes of death for 20 age groups in 1990 and 2010: a systematic analysis for the Global Burden of Disease Study 2010. Lancet. 2012;380:2095-2128.
2. Murray CJ, Vos T, Lozano R, Naghavi M, Flaxman AD, Michaud C, et al. Disability-adjusted life years (DALYs) for 291 diseases and injuries in 21 regions, 1990-2010: a systematic analysis for the Global Burden of Disease Study 2010. Lancet. 2012;380:2197-2223.
3. International Diabetes Federation (IDF) [Internet]. Country estimates table 2011. IDF diabetes atlas. 6th ed, 2012. Accessed 7 Jun 2013 http://www.idf.org/sites/default/files/EN-6E-Atlas-Full-0.pdf.
4. American Diabetes Association. Diagnosis and classification of diabetes mellitus. Diabetes Care. 2013;36:S67-S74.
5. American Diabetes Association. Standards of medical care in diabetes. Diabetes Care. 2012;35:S11-S63.
6. DeFronzo R. From the triumvirate to the ominous octet: a new paradigm for the treatment of type diabetes mellitus. Diabetes. 2009;58:773-795.
7. Goldberg RB, Holman R, Drucker DJ. Management of type 2 diabetes. N Engl J Med. 2008;358:293-297.
8. Maity P, Hansda D, Bandyopadhyay U, Mishra DK. Biological activities of crude and chemical constituents of Bael, Aegle marmelos (L.) Corr. Indian J Exp Biol. 2009;47:849-861.
9. Kumar V, Ahmed D, Anwar F, Ali M, Mujeeb M. Enhanced glycemic control, pancreas protective, antioxidant and hepatoprotective effects by umbelliferon-D-glucopyranosyl-(2(I) ? 1(II))-D-glucopyranoside in streptozotocin induced diabetic rats. Springerplus. 2013;2:639.
10. Gandhi GR, Ignacimuthu S, Paulraj MG. Hypoglycemic and-cells regenerative effects of Aegle marmelos (L.) Corr. bark extract in streptozotocin-induced diabetic rats. Food Chem Toxicol. 2012;50:1667-1674.
11. Narendhirakannan R, Subramanian S. Biochemical evaluation of the protective effect of Aegle marmelos (L.), Corr. leaf extract on tissue antioxidant defense system and histological changes of pancreatic beta-cells in streptozotocin-induced diabetic rats. Drug Chem Toxicol. 2010;33:120-130.
12. Narendhirakannan RT, Subramanian S, Kandawamy M. Biochemical evaluation of antidiabetogenic properties of some commonly used Indian plants on streptozotocin-induced diabetes in experimental rats. Clin Exp Pharmacol Physiol. 2006;33:1150-1157.
13. Ramesh B, Pugalendi KV. Inflluence of umbelliferone on membrane-bound ATPases in streptozotocin-induced diabetic rats. Pharmacol Rep. 2007;59:339-348.
14. Kamalakkanan N, Prince PS. Antihyperlipidemic effect of water extract of Aegle marmelos fruit extract in streptozotocin induced diabetes rats. J Sci Food Agric. 2005;85:569-574.
15. Upadhya S, Shanbhag KK, Suneetha G, Balachandra Naidu M. A study of hypoglycemic and antioxidant activity of Aegle marmelos in alloxan induced diabetic rats. Indian J Physiol Pharmacol. 2004;48:476-480.
16. Sabu MC, Kuttan R. Antidiabetic activity of Aegle marmelos and its relationship with its antioxidant properties. Indian J Physiol Pharmacol. 2004;48:81-88.
17. Ponnachan PT, Paulose CS, Panikkar KR. Effect of leaf extract of Aegle marmelose in diabetic rats. Indian J Exp Biol. 1993;4:345-347.
18. Saravanan M, Pandikumar P, Saravanan S, Toppo E, Pazhanivel N, Ignacimuthu S. Lipolytic and antiadipogenic effects of (3, 3-dimethylallyl) halfordinol on 3T3-L1 adipocytes and high fat and fructose diet induced obese C57/BL6J mice. Eur J Pharmacol. 2014;740:714-721.
19. Sharma AK, Bharti S, Goyal S, Arora S, Nepal S, Kishore K, et al. Upregulation of PPAR by Aegle marmelos ameliorates insulin resistance and-cell dysfunction in high fat diet fed-streptozotocin induced type 2 diabetic rats. Phytother Res. 2011;10:1457-1465.
20. Devi K, Silvaraj A, Vinoth PK, Syed ZA, Sathiaraj K, Senthil BK, et al. Hypolipidemic effect of Aegle marmelos leaf extract in streptozotocin (STZ) induced diabetic male albino rats. Int J Pharmtech Res. 2010;1:259-265.
21. Bonner-Weir S, Trent DF, Honey RN, Weir GC. Responses of neonatal rat islets to streptozotocin: limited B-cell regeneration and hyperglycemia. Diabetes. 1981;30:64-69.
22. Ansari A, Shahriar MS, Hassan MM, Das SR, Rokeya B, Haque MA, et al. Emblica officinalis improves glycemic status and oxidative stress in STZ induced type 2 diabetic model rats. Asian Pac J Trop Med. 2014;7:21-25.
23. Moniruzzaman M, Rokeya B, Ahmed S, Bhowmik A, Khalil MI, Gan SH. In vitro antioxidant effects of Aloe barbadensis Miller extracts and the potential role of these extracts as antidiabetic and antilipidemic agents on strepptozotocin-induced type 2 diabetic model rats. Molecules. 2012;17:12851-12867.
24. Ali L, Khan AK, Mamun MI, Mosihuzzaman M, Nahar N, Nur-e-Alam M, et al. Studies on hypoglycemic effects of fruit pulp seed and whole plant of Momordica charantia on normal and diabetic model rats. Planta Med. 1993;59:408-412.
25. Sivaraj A, Devi K, Palani S, Vinoth PK, Sennthil BK, David E. Anti-hyperglycemic and anti-hyperlipidemic effect of combined plant extract of Cassia auriculata and Aegle marmelos in streptozotocin (STZ) induced diabetic albino rats. Int J Pharmtech Res. 2009;1:1010-1016.
26. Friedewald WT, Levy RI, Fredrickson DS. Estimation of concentration of low-density lipoprotein cholesterol without the use of preparative ultracentrifuge. Clin Chem. 1972;18:449.
27. Mathews DR, Hosker JP, Rudenski AS, Naylor BA, Teacher DF, Turner RC. Homeostasis model assessment: insulin resistance and-cell function from fasting plasma glucose and insulin concentration in man. Diabetologia. 1985;28:412-419.
28. Arulmozhi DK, Veerranjaneyulu A, Bodhankar SL. Neonatal streptozotocin-induced rat model of Type 2 diabetes mellitus. Indian J Pharmacol. 2004;4:217-221.
29. Islam MS, Loots du T. Experimental rodent models of type 2 diabetes: a review. Methods Find Exp Clin Pharmacol. 2009;31:249-261.
30. Adisakwattana S, Ruengsamran T, Kampa P, Sompong W. In vitro inhibitory effects of plant-based foods and their combinations on intestinal-glucosidase and pancreatic-amylase. BMC Complement Altern Med. 2012;12:110.
31. Saha S, Verma R. Inhibitory potential of traditional herbs on-amylase activity. Pharm Biol. 2012;50:326-331.
32. Gautam S, Ishrat N, Singh R, Narender T, Srivastava AK. Aegeline from Aegle marmelos stimulates glucose transport via Akt and Rac1 signaling, and contributes to a cytoskeletal rearrangement through PI3K/Rac1. Eur J Pharmacol. 2015;762:419-429.